ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


Trial of Eculizumab for HUS approved

26th December 2015

The trial for the drug Eculizumab for HUS sufferers has been approved. The study is known as the ECUSTEC. The drug is currently being used by aHUS sufferers. The Charity welcomes the trial which will start in 2016 as it is hoped that it will help improve the outcome for sufferers of HUS. To date there has been no specific treatment.

The Charity is one of the co-applicants for the drug based on the fact that there has been no such treatments previously. Whilst only time will tell whether or not the drug will work, we can only hope that it will be beneficial long term for such sufferers. The trial will take several years to complete.




Page
1 of 50
Next > Last >>

27th May 2025

There were 2063 cultured confirm... ...read on
24th April 2025

16th April 2025    Case Reference: IC-348... ...read on
5th March 2025

The Information Commissioner's office (ICO) Freedom of Information decision notice of 05/03/2025 stated    ... ...read on
14th February 2025

At any price point, the food you purchase should be safe whatever your dietary requirements are. However foodborne illness is estimated to cost 10.4 billion pounds annually in the UK by government. ... ...read on
22nd December 2024

UK Health Security Agency  By email  ste... ...read on
Page
1 of 50
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy